Patients with Type 2 Diabetes and Residual Insulin Secretory Capacity Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring.
Sarah A PuhrJohn B WelshColleen E BauzaTomas C WalkerPublished in: Journal of diabetes science and technology (2021)